Healthcare public relations in the Netherlands: what international health companies need to know
Healthcare public relations in the Netherlands: what international health companies need to know
Rob Lagendijk
Rob Lagendijk
24 October 2026
International healthcare, healthtech and MedTech companies often enter the Netherlands with a communication model that worked well in another market. The press release is translated, the global proof points are reused and the same launch story is offered to Dutch media.
International healthcare, healthtech and MedTech companies often enter the Netherlands with a communication model that worked well in another market. The press release is translated, the global proof points are reused and the same launch story is offered to Dutch media.
That is usually not enough. The Dutch healthcare market is compact, highly connected and professionally critical. A company needs more than visibility. It needs a position that healthcare executives, professionals, journalists and potential partners can understand and trust.
That is usually not enough. The Dutch healthcare market is compact, highly connected and professionally critical. A company needs more than visibility. It needs a position that healthcare executives, professionals, journalists and potential partners can understand and trust.
Dutch healthcare PR starts with relevance, not translation
Dutch healthcare PR starts with relevance, not translation
A global company story can be useful background, but Dutch media and healthcare stakeholders want to know what changes here. Which healthcare problem does the company address in the Netherlands? Who experiences that problem? What evidence is relevant to Dutch practice? And why should the market pay attention now?
A global company story can be useful background, but Dutch media and healthcare stakeholders want to know what changes here. Which healthcare problem does the company address in the Netherlands? Who experiences that problem? What evidence is relevant to Dutch practice? And why should the market pay attention now?
The strongest market entry stories are therefore localised rather than translated. They connect the international proposition to a recognisable Dutch healthcare challenge.
The strongest market entry stories are therefore localised rather than translated. They connect the international proposition to a recognisable Dutch healthcare challenge.
The Netherlands is a small market with many decision makers
The Netherlands is a small market with many decision makers
The country is geographically small, but adoption in healthcare can involve clinicians, hospital boards, general practitioners, procurement teams, insurers, patient organisations, technology partners and policymakers.
The country is geographically small, but adoption in healthcare can involve clinicians, hospital boards, general practitioners, procurement teams, insurers, patient organisations, technology partners and policymakers.
Those audiences do not evaluate the same story in the same way. A journalist may look for societal relevance. A clinician wants to understand evidence and workflow. An executive needs to see strategic value and risk. Good public relations connects one credible position to those different questions.
Those audiences do not evaluate the same story in the same way. A journalist may look for societal relevance. A clinician wants to understand evidence and workflow. An executive needs to see strategic value and risk. Good public relations connects one credible position to those different questions.
Earned media is not the same as launch publicity
Earned media is not the same as launch publicity
A funding round, product launch or new Dutch office can create a communications moment. It does not automatically create editorial relevance.
A funding round, product launch or new Dutch office can create a communications moment. It does not automatically create editorial relevance.
Dutch journalists are more likely to respond when a company can contribute something useful to a wider issue: access to care, workforce pressure, digitalisation, diagnostics, prevention, patient experience or the responsible use of AI. The product becomes stronger when it helps explain the issue instead of demanding attention on its own.
Dutch journalists are more likely to respond when a company can contribute something useful to a wider issue: access to care, workforce pressure, digitalisation, diagnostics, prevention, patient experience or the responsible use of AI. The product becomes stronger when it helps explain the issue instead of demanding attention on its own.
Evidence matters more than superlatives
Evidence matters more than superlatives
Healthcare claims are examined closely. Statements about better outcomes, lower workload, faster diagnosis or improved access need context. What was measured? In which population? Over what period? Was the result a pilot, an operational outcome or a clinical finding?
Healthcare claims are examined closely. Statements about better outcomes, lower workload, faster diagnosis or improved access need context. What was measured? In which population? Over what period? Was the result a pilot, an operational outcome or a clinical finding?
International companies sometimes lose credibility by bringing investor language into a healthcare conversation. Clear boundaries around what is proven, plausible and still being investigated often create more trust than a stronger claim.
International companies sometimes lose credibility by bringing investor language into a healthcare conversation. Clear boundaries around what is proven, plausible and still being investigated often create more trust than a stronger claim.
The spokesperson is part of the positioning
The spokesperson is part of the positioning
The best spokesperson is not always the most senior executive. Dutch media may need a medical expert, an implementation partner, a local market lead or a customer who can explain what the innovation changes in practice.
The best spokesperson is not always the most senior executive. Dutch media may need a medical expert, an implementation partner, a local market lead or a customer who can explain what the innovation changes in practice.
Before outreach, decide which questions each spokesperson can answer credibly and where the limits of their expertise are. That preparation matters more in healthcare than rehearsing one polished key message.
Before outreach, decide which questions each spokesperson can answer credibly and where the limits of their expertise are. That preparation matters more in healthcare than rehearsing one polished key message.
Market entry PR should support adoption
Market entry PR should support adoption
Public relations creates the most value when it supports a broader market entry strategy. Media visibility can strengthen credibility, make an unfamiliar category easier to understand and give commercial conversations independent context.
Public relations creates the most value when it supports a broader market entry strategy. Media visibility can strengthen credibility, make an unfamiliar category easier to understand and give commercial conversations independent context.
It cannot replace product market fit, procurement readiness, evidence or local stakeholder relationships. If those foundations are weak, publicity can expose the gap instead of solving it.
It cannot replace product market fit, procurement readiness, evidence or local stakeholder relationships. If those foundations are weak, publicity can expose the gap instead of solving it.
When do you need a Dutch healthcare PR partner?
When do you need a Dutch healthcare PR partner?
A local PR partner becomes useful when the challenge is not simply translation but interpretation: which Dutch healthcare themes matter, how should evidence be framed, which journalists are relevant, which claims will be questioned and how should the company position itself before entering the public debate.
A local PR partner becomes useful when the challenge is not simply translation but interpretation: which Dutch healthcare themes matter, how should evidence be framed, which journalists are relevant, which claims will be questioned and how should the company position itself before entering the public debate.
For international health companies, the objective should not be maximum coverage. It should be credible relevance in the market you want to enter.
For international health companies, the objective should not be maximum coverage. It should be credible relevance in the market you want to enter.
A practical market entry checklist
A practical market entry checklist
Can we explain the Dutch healthcare problem we help solve? Do we have evidence that is understandable outside our own company? Is it clear which stakeholders need to trust us? Do we know which claims require qualification? Do we have a spokesperson who can handle critical questions? Is there a reason for Dutch media to care now?
Can we explain the Dutch healthcare problem we help solve? Do we have evidence that is understandable outside our own company? Is it clear which stakeholders need to trust us? Do we know which claims require qualification? Do we have a spokesperson who can handle critical questions? Is there a reason for Dutch media to care now?
If those answers are clear, earned media can become a powerful part of market entry. If they are not, positioning should come first.
If those answers are clear, earned media can become a powerful part of market entry. If they are not, positioning should come first.